Chelation therapy is a medical treatment that uses special drugs to pull toxic metals out of your body. These drugs, called chelating agents, bind to metals like lead, iron, mercury, and arsenic in your bloodstream and tissues, forming compounds your kidneys can filter into urine. The FDA has approved 11 chelating agents for treating specific types of metal poisoning and metal overload conditions, and all require a prescription.
How Chelation Works in Your Body
Chelating agents are molecules with atoms (typically sulfur, nitrogen, or oxygen) that latch onto metal ions floating in your blood or lodged in your tissues. When a chelating agent encounters a metal ion, it wraps around it and forms a ring-like structure called a chelate. This new compound is water-soluble, which means your kidneys can recognize it and flush it out through urine.
Different chelating agents work in slightly different ways. Some completely surround the metal ion, neutralizing it so it can no longer cause damage. The iron chelator deferoxamine, for example, fully covers the surface of iron ions, which prevents those ions from triggering harmful chemical reactions in your cells. Others form a more open, basket-like structure around the metal. EDTA, one of the most widely used chelating agents, wraps around metals this way, which is effective for removal but doesn’t fully shield the metal during the process.
Some chelating agents stay mostly in your bloodstream and are good at pulling metals circulating outside your cells. Others can cross into cells to reach metals stored deeper in tissues, though this is harder to do. The choice of agent depends largely on which metal needs to be removed and where it has accumulated.
Approved Medical Uses
Chelation therapy has clear, well-established roles in treating metal poisoning and certain conditions involving metal buildup. The specific agent used depends on which metal is involved.
- Lead poisoning: Calcium EDTA is approved for lead poisoning in general, while succimer (DMSA) is approved specifically for children with blood lead levels above 45 micrograms per deciliter. Dimercaprol can also be used for acute lead poisoning alongside calcium EDTA.
- Iron overload: Deferoxamine is used for acute iron poisoning and for chronic iron overload in people who receive frequent blood transfusions, such as those with thalassemia. Two oral alternatives, deferasirox and deferiprone, are also approved for chronic iron overload.
- Arsenic and mercury poisoning: Dimercaprol is the primary approved agent for arsenic and mercury. Succimer is also used off-label for both.
- Copper storage disease (Wilson’s disease): Penicillamine, an oral chelator, is approved for this genetic condition where copper accumulates in the liver and brain.
- Radioactive contamination: Calcium DTPA and zinc DTPA were approved in 2004 to help the body eliminate plutonium, americium, and curium after exposure to radioactive materials.
- Thallium and cesium poisoning: Prussian blue, approved in 2003, treats these uncommon but dangerous poisonings.
What Treatment Looks Like
The experience of chelation therapy varies depending on the condition being treated and the agent being used. Some chelators are taken as pills, while others are given through an IV.
For IV-based treatments, particularly those using EDTA, sessions typically last around three hours. These infusions are usually given once a week, and a full course can range from 20 to 40 sessions spread over many months. That’s a significant time commitment: a 40-session course takes a little over a year to complete. Oral chelators like succimer or penicillamine are taken at home on a set schedule, which is more convenient but still requires regular blood work to monitor how your body is responding.
During treatment, your doctor will check your kidney function and blood mineral levels regularly, since chelating agents don’t exclusively target toxic metals. They can also pull out essential minerals your body needs.
Risks and Side Effects
Chelating agents are powerful drugs, and their ability to grab metals isn’t perfectly selective. While they target the toxic metal in question, they can also bind to essential minerals like calcium, zinc, and copper, potentially dropping those levels too low. This is why chelation is only used under medical supervision, with blood tests to track mineral levels throughout treatment.
Kidney stress is a real concern, since the kidneys do the heavy lifting of filtering out the metal-chelator complexes. People with existing kidney problems are at higher risk for complications. Some chelators can cause mild liver enzyme elevations or allergic reactions. Succimer, for instance, has been linked to both of these in a small number of patients.
The most dangerous complications tend to happen when chelation is administered incorrectly. Using the wrong agent, the wrong dose, or the wrong route of administration can have serious consequences, which is one reason every FDA-approved chelation product is prescription-only. No chelation products have ever been approved for over-the-counter use.
Chelation for Heart Disease
One of the most debated uses of chelation therapy is for cardiovascular disease. The idea is that EDTA might remove calcium deposits from clogged arteries or reduce toxic metal levels that contribute to heart damage. This hypothesis led to two large clinical trials funded by the National Institutes of Health.
The first Trial to Assess Chelation Therapy (TACT) suggested a possible benefit for heart attack survivors with diabetes, which prompted a follow-up study. TACT2, published in JAMA, specifically enrolled patients with both diabetes and a prior heart attack to test whether EDTA chelation could reduce major cardiovascular events like heart attacks, strokes, and death. The results were not encouraging. About 35.6% of patients receiving EDTA chelation and 35.7% of patients receiving a placebo experienced a major cardiovascular event, a difference that was essentially zero. The hazard ratio was 0.93, and the result was not statistically significant. For the more serious combination of heart attack, stroke, or cardiovascular death specifically, rates were 18.4% with chelation versus 19.7% with placebo, also not a meaningful difference.
Based on this evidence, chelation therapy for heart disease remains unproven. Major medical organizations do not recommend it as a cardiovascular treatment.
Unproven Uses and Concerns
Beyond heart disease, chelation therapy has been promoted for conditions including autism spectrum disorders, Alzheimer’s disease, and various chronic illnesses. None of these uses have compelling evidence behind them.
The use of chelation in children with autism has drawn particular concern from medical experts. Some practitioners have administered various chelating agents to children with autism under the theory that mercury or other metals are contributing to their symptoms. A review published in BMJ found that the available information on this practice was scant, and what did exist suggested that inappropriate agents, routes, or dosage schedules were being used. There is no compelling evidence that chelation is an effective treatment for autism, and at least one child’s death has been linked to an error during chelation administration.
The cost of chelation also matters here. Sessions are not inexpensive, and when the treatment is being used for unapproved indications, insurance typically does not cover it. Families pursuing chelation for conditions like autism bear both the financial burden and the risk of side effects for a treatment with no demonstrated benefit.
The FDA has specifically warned against unapproved chelation products sold online or over the counter, including sprays, suppositories, and dietary supplements that claim to detoxify the body of heavy metals. These products are not regulated for safety or effectiveness and carry real risks.